Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Platelet-rich plasma (PRP) combined with lidocaine is a therapeutic approach that utilizes a patient's own concentrated platelets mixed with a local anesthetic. PRP is derived from the patient's blood, which is centrifuged to isolate and concentrate platelets that contain growth factors essential for tissue repair and regeneration. Lidocaine is added to reduce pain and discomfort during the injection procedure. This combination maintains the therapeutic potential of platelets while providing pain relief during administration. The growth factors released from platelets stimulate and accelerate the body's natural healing processes, promoting tissue repair in damaged areas.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on platelet-rich plasma + lidocaine.